Literature DB >> 11356646

Nitric oxide synthase in porcine heart mitochondria: evidence for low physiological activity.

S French1, C Giulivi, R S Balaban.   

Abstract

The capacity of isolated porcine heart mitochondria to produce nitric oxide (NO) via mitochondrial NO synthase (NOS) was evaluated. The mitochondrial NOS content and activity (0.2 nmol NO x mg mitochondrial protein(-1) x min(-1)) were approximately 10 times lower than previously reported for the rat liver. No evidence for mitochondrial NOS-generated NO was found in mitochondrial suspensions based on the lack of NO production and the lack of effect of either L-arginine or NOS inhibitors on the rate of respiration. The reason that even the low mitochondrial NOS activity did not result in net NO production and metabolic effects is because the mitochondrial metabolic breakdown of NO (1-4 nmol NO x mg mitochondrial protein(-1) x min(-1)) was greater than the maximum rate of NO production measured in homogenates. These data suggest that NO production at the mitochondria via NOS is not a significant source of NO in the intact heart and does not regulate cardiac oxidative phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356646     DOI: 10.1152/ajpheart.2001.280.6.H2863

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  21 in total

Review 1.  Heart mitochondria signaling pathways: appraisal of an emerging field.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

Review 2.  What can we learn about cardioprotection from the cardiac mitochondrial proteome?

Authors:  Marjan Gucek; Elizabeth Murphy
Journal:  Cardiovasc Res       Date:  2010-08-30       Impact factor: 10.787

3.  Modulation of peroxynitrite produced via mitochondrial nitric oxide synthesis during Ca2+ and succinate-induced oxidative stress in cardiac isolated mitochondria.

Authors:  Harrison J Gerdes; Meiying Yang; James S Heisner; Amadou K S Camara; David F Stowe
Journal:  Biochim Biophys Acta Bioenerg       Date:  2020-08-20       Impact factor: 3.991

4.  Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes.

Authors:  Xin-Wen Yu; Qian Chen; Richard H Kennedy; Shi J Liu
Journal:  J Physiol       Date:  2005-04-21       Impact factor: 5.182

5.  In vivo microscopy reveals extensive embedding of capillaries within the sarcolemma of skeletal muscle fibers.

Authors:  Brian Glancy; Li-Yueh Hsu; Lam Dao; Matthew Bakalar; Stephanie French; David J Chess; Joni L Taylor; Martin Picard; Angel Aponte; Mathew P Daniels; Shervin Esfahani; Samuel Cushman; Robert S Balaban
Journal:  Microcirculation       Date:  2014-02       Impact factor: 2.628

Review 6.  Mathematical and computational models of oxidative and nitrosative stress.

Authors:  Mahendra Kavdia
Journal:  Crit Rev Biomed Eng       Date:  2011

Review 7.  Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion.

Authors:  Giancarlo Solaini; David A Harris
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

8.  Hypoxia/reoxygenation of isolated rat heart mitochondria causes cytochrome c release and oxidative stress; evidence for involvement of mitochondrial nitric oxide synthase.

Authors:  Woineshet J Zenebe; Rafal R Nazarewicz; Mordhwaj S Parihar; Pedram Ghafourifar
Journal:  J Mol Cell Cardiol       Date:  2007-06-02       Impact factor: 5.000

Review 9.  Mitochondrial nitric-oxide synthase: enzyme expression, characterization, and regulation.

Authors:  Virginia Haynes; Sarah Elfering; Nathaniel Traaseth; Cecilia Giulivi
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

10.  Arginase activity in mitochondria--An interfering factor in nitric oxide synthase activity assays.

Authors:  Priya Venkatakrishnan; Ernesto S Nakayasu; Igor C Almeida; R T Miller
Journal:  Biochem Biophys Res Commun       Date:  2009-11-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.